Jasmohan S. Bajaj, Nita H. Salzman, Chathur Acharya, Richard K. Sterling, Melanie B. White, Edith A. Gavis, Andrew Fagan, Michael Hayward, Mary L. Holtz, Scott Matherly, Hannah Lee, Majdi Osman, Mohammad S. Siddiqui, Michael Fuchs, Puneet Puri, Masoumeh Sikaroodi, Patrick M. Gillevet – 30 April 2019 – Hepatic encephalopathy (HE) can cause major morbidity despite standard of care (SOC; rifaximin/lactulose). Fecal microbial transplant (FMT) enemas postantibiotics are safe, but the effect of FMT without antibiotics using the capsular route requires investigation.

Silvia Nardelli, Barbara Lattanzi, Manuela Merli, Alessio Farcomeni, Stefania Gioia, Lorenzo Ridola, Oliviero Riggio – 30 April 2019 – Muscle alterations (myosteatosis and sarcopenia) are frequent in cirrhosis and related to some complications including overt hepatic encephalopathy (HE). The aim of our study was to investigate the relationship between muscle alterations and minimal HE (MHE) and their role in the risk of overt HE. Sixty‐four patients with cirrhosis were administered the Psychometric Hepatic Encephalopathy Score and animal naming test to detect MHE.

Jody C. Olson – 30 April 2019

Christopher Kasia, Steven J. Scaglione – 30 April 2019

Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn – 30 April 2019

Bashar Attar – 30 April 2019

Tatyana Kushner, Rhoda S. Sperling, Douglas Dieterich – 30 April 2019

Daniel Berger, Vishal Desai, Sujit Janardhan – 30 April 2019

Raymond J. Lynch, Fei Ye, Quanhu Sheng, Zhiguo Zhao, Seth J. Karp – 30 April 2019

Malcolm R. Alison, Wey‐Ran Lin – 29 April 2019